2023
Exports
$6.01BWorld Rnk 14 / 208
Flag Rnk 7 / 1215
2023
PRODUCT COMPLEXITY IN Vaccines, blood, antisera, toxins and cultures
1.25Rnk 89 / 1025
2023
Imports
$6BWorld Rnk 14 / 222
Flag Rnk 8 / 1214
2023
ECONOMIC COMPLEXITY of Spain
0.86Rnk 31 / 132

About

Exports In 2023, Spain exported $6.01B in Vaccines, blood, antisera, toxins and cultures, making it the 14th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 7th most exported product in Spain. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Spain are: United States ($969M), Belgium ($962M), Japan ($855M), Ireland ($575M), and Germany ($345M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Spain between 2022 and 2023 were Belgium ($893M), Israel ($109M), and Hungary ($57.7M).

Imports In 2023, Spain imported $6B in Vaccines, blood, antisera, toxins and cultures, becoming the 14th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 8th most imported product in Spain. Spain imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($1.48B), Switzerland ($1.09B), Germany ($1.07B), Netherlands ($940M), and Belgium ($503M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Spain between 2022 and 2023 were Netherlands ($253M), United States ($110M), and Argentina ($34.4M).

Latest Trends

November 2024

Subnational Monthly Trade

Time Scale
Flow
Color
EXPORT GROWTH (November 2023 - November 2024)€74M(24.2%)
IMPORT GROWTH (November 2023 - November 2024)€119M(24%)
MAIN EXPORTER (November 2024)Madrid€219M
MAIN DESTINATION (November 2024)Belgium€79.4M

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for Spain. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2023)$6.01B
IMPORTS (2023)$6B
NET TRADE (2023)$9.96M

In 2023, Spain exported $6.01B in Vaccines, blood, antisera, toxins and cultures. The main destinations of Spain exports on Vaccines, blood, antisera, toxins and cultures were United States ($969M), Belgium ($962M), Japan ($855M), Ireland ($575M), and Germany ($345M).

In 2023, Spain imported $6B in Vaccines, blood, antisera, toxins and cultures, mainly from United States ($1.48B), Switzerland ($1.09B), Germany ($1.07B), Netherlands ($940M), and Belgium ($503M).

Explore Visualizations

Export Destinations (2023)

Import Origins (2023)

Market Growth

Flow
THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR Spain WERE (2022 - 2023):
Belgium$893M (1.29k%)
Israel$109M (1.48k%)
Hungary$57.7M (851%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY Spain WERE (2022 - 2023):
Japan-$1.86B (-68.5%)
Germany-$1.11B (-76.3%)
United Kingdom-$698M (-92.9%)

Change in Exports by Market (2022 - 2023)

Market Concentration

View
Flow
Type
In 2023, Spain's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:
In 2023, Spain's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:

Explore Visualizations

Trade Value of Vaccines, blood, antisera, toxins and cultures by Exporters

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALUnited States+ $393M
TOP IMPORT POTENTIALGermany+ $230M

Vaccines, blood, antisera, toxins and cultures’s highest export potential is United States. With an export gap of $393M.   Vaccines, blood, antisera, toxins and cultures’s highest import potential is Germany with an import gap of $230M.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with